Concepedia

Chronic Oral Administration of CI-994: A Phase I Study

Sucharu Prakash, Brenda J. Foster, Mark Meyer, Antoinette Wozniak, Lance K. Heilbrun, Lawrence E. Flaherty, Mark M. Zalupski, Louis L. Radulovic, Manuel Valdivieso, Patricia LoRusso

Investigational New Drugs · 2001 · 135 citations · 9 references

DOI

Concepts

References

9

Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.

Thomas H. Corbett, Bill J. Roberts, Wilbur R. Leopold et al. · PubMed · 1984 · 357 citations

, , +12

Preclinical antitumor activity of CI-994

Patricia LoRusso, Lisa Demchik, Brenda J. Foster et al. · Investigational New Drugs · 1996 · 55 citations

, , +4

Synthesis, toxicity, and therapeutic efficacy of 4-amino-N-(2'-aminophenyl)-benzamide: a new compound preferentially active in slowly growing tumors.

Michael Berger, H. Bischoff, E Fritschi et al. · PubMed · 1985 · 28 citations

, , +13

Preclinical toxicity of a new oral anticancer drug, CI-994 (Acetyldinaline), in rats and dogs

Michael J. Graziano, GaryD. Pilcher, Kathleen M. Walsh et al. · Investigational New Drugs · 1997 · 21 citations

, , +14

Effectiveness of P-aminobenzyol-O-phenylenediamine (Goe 1734) against mouse, rat, and human tumour cells

P. Lelieveld, R. J. F. Middeldorp, L. M. van Putten · Cancer Chemotherapy and Pharmacology · 1985 · 17 citations

, , +5